Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.42.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.348EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.459EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.415.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.243.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.98EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.566EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.480EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.579EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.11 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.435EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.445EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.124EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.384EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAQEWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BA.2.3.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
B.1.569EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.524EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.596.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.473EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.76.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.595.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.495EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.294EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.453EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.350EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.304EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.315EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.516EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.354EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.162EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.426EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.402EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.424EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.264EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.581EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.330EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.205EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.177EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used